Appeal No. 1995-1989 Application 07/850,142 as being based on a non-enabling disclosure when s/he has reason to conclude that one skilled in the art would be unable to carry out the claimed invention. In re Buchner, 929 F.2d 660, 661, 18 USPQ2d 1331, 1332 (Fed. Cir. 1991). Here, we do not find that the examiner has provided any reasons or factual basis as to why one skill in the art would doubt the specification statements. That is, the examiner has not provided any reasons or factual basis to support her conclusion that the method of making monoclonal antibodies having the claimed properties as described on pp. 11-14 of the specification is not reproducible. To the contrary, we find that she is shifting the burden to the appellants to demonstrate, or to provide evidence, that their procedure is reproducible. Accordingly, the rejection is reversed. The Rejections under 35 U.S.C. § 103 The examiner has premised her various conclusions of obviousness on the teachings of Behan, Sevier, Cooper and the Sigma catalog. However, we agree with the appellants that none of the cited references teaches or suggests the claimed (i) diagnostic method, (ii) monoclonal antibodies having the specified binding characteristics, or (iii) kits for diagnosing AD which employ said monoclonals. In our review of the applied prior art we do not find that any of the references even allude to monoclonal antibodies which bind specifically, and to a statistically greater degree, to acute phase reactant antigens in a sample derived from a subject having AD than to a 6Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007